Secteur Taysha Gene Therapies, Inc.

Actions

TSHA

US8776191061

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:25:08 24/07/2026 Varia. 5j. Varia. 1 janv.
5,515 USD -5,40% Graphique intraday de Taysha Gene Therapies, Inc. -7,05% +0,73%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-5,40%-7,05%-20,17%-13,44%+0,73%+113,90%+727,11%-69,14% - 1,86 Md
-1,92%-1,57%+17,58%+24,76%+37,91%+48,70%+84,37%-18,83% - 55,92 Md
+0,93%+6,97%+7,45%+20,74%+12,22%+62,83%+67,97%+207,26%+6 092,46% 56,67 Md
-2,42%-1,86%-0,48%-14,87%-5,69%-21,64%-16,12%-68,64% - 23,28 Md
-0,04%-1,07%+3,58%-20,72%-38,43%+3,52%+423,78%+348,39%+868,07% 23,28 Md
-0,36%-0,56%+25,56%+15,27%+24,36%+36,00%-3,93%-69,85% - 20,54 Md
-1,34%+0,51%+10,11%+9,79%-7,33%+25,02%-30,27%-32,93%+64,06% 17,78 Md
-1,44%-1,63%+29,15%+10,63%+31,06%+37,07%+589,93% - - 15,9 Md
-1,30%-9,92%+14,98%+100,16%+167,88%+160,67%+284,37%+1 494,96%+602,10% 14,64 Md
-0,58%-0,84%+4,88%+23,39%+26,51%+23,80%+178,78%+235,86%+536,62% 13,99 Md
-0,75%+15,96%+7,96%+16,57%+29,78%+429,89%+145,75%+29,12%+1 424,96% 12,22 Md
-0,28%-1,86%+6,55%+6,01%-6,73%+81,56%+164,08%+535,88% - 12,53 Md
-3,21%-2,26%+16,37%-23,70%-11,95%-30,61%+167,47%+87,91% - 12,08 Md
-8,58%-0,25%-3,33%-37,61%-21,24%-50,04%+592,21%+80,54%+92,66% 11,63 Md
-1,01%+1,38%+0,11%+24,45%+27,94%+117,88%+147,16%+188,26%+722,77% 11,12 Md
-4,70%-2,12%+24,46%-20,53%+15,56%+25,11%+91,26%-12,93% - 8,82 Md
+0,09%-0,16%+131,43%+118,45%+79,87%+175,34%+351,62%+355,30% - 8,82 Md
+0,76%+1,12%+17,52%+45,47%+209,37%+475,85%+587,12%-37,53%-10,11% 8,79 Md
-4,27%-3,92%+35,99%+23,73%+14,49%+24,13%+323,29%+313,02% - 8,27 Md
-1,07%-2,02%+2,22%-7,44%+19,34%+51,95%+16,44%+143,44% - 8,03 Md
Moyenne -1,87%+1,82%+16,60%+15,06%+30,28%+89,55%+244,62%+195,27%+1 154,84% 17,31 Md
Moyenne pondérée par Capi. -1,29%+2,21%+14,67%+15,55%+24,95%+68,57%+176,49%+175,12%+2 406,33%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TSHA
  4. Secteur Taysha Gene Therapies, Inc.